Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
about
Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsementCost analysis of Human Papillomavirus-related cervical diseases and genital warts in SwazilandThe economic burden of human papillomavirus-related precancers and cancers in Sweden.Parents' views of including young boys in the Swedish national school-based HPV vaccination programme: a qualitative study.Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology.Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.Progress in HPV vaccination in low- and lower-middle-income countries.Nordic Cancer Registries - an overview of their procedures and data comparability.Reduction in the burden of hospital admissions due to cervical disease from 2003-2014 in Spain.STI Knowledge in Berlin Adolescents.Differential misclassification between self-reported status and official HPV vaccination records in Japan: Implications for evaluating vaccine safety and effectiveness.Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort studyImpact of HPV-vaccination on outcome of cervical cytology screening in Denmark - a register based cohort study
P2860
Q28069669-D6060EF6-2146-4CDA-AB22-5CADE73FD798Q33713018-F835F625-1FED-4320-B53E-F3D37D66A393Q33834660-0A91523F-C555-406D-8DA5-B9D83E693593Q37681398-12E389EB-85D6-4931-B218-44F02BC0B6E6Q38673879-B920AFA8-36C8-4CAF-8143-86B7B6F54816Q38733067-F6319961-7F98-4933-918A-F8F499B883ADQ39158741-BD4329CE-D28D-4086-9C25-5FA108871610Q47332633-E97785EA-B5F9-4D82-8912-6A1E7C7AF1DCQ47367286-4EBCBD50-DBD1-4799-A0CD-1ADBAA1B2B80Q47555628-79291714-7BA0-4621-A6C0-E1099DFEF77EQ55093583-A236ABCD-F4F9-4612-96C4-F441C5916BA5Q55261252-468CBBC8-3E04-4BAB-BE12-39FB47E009B4Q57044279-1F4E79CE-A193-43D2-B078-ACDC5876AC13Q58766182-AA5635C5-97F9-4886-9A14-E8CCC9FBA6DD
P2860
Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quadrivalent HPV vaccine effec ...... tion: A population-based study
@en
Quadrivalent HPV vaccine effec ...... ion: A population-based study.
@nl
type
label
Quadrivalent HPV vaccine effec ...... tion: A population-based study
@en
Quadrivalent HPV vaccine effec ...... ion: A population-based study.
@nl
prefLabel
Quadrivalent HPV vaccine effec ...... tion: A population-based study
@en
Quadrivalent HPV vaccine effec ...... ion: A population-based study.
@nl
P2860
P50
P356
P1476
Quadrivalent HPV vaccine effec ...... tion: A population-based study
@en
P2093
Eva Herweijer
Pär Sparén
P2860
P304
P356
10.1002/IJC.30035
P577
2016-03-09T00:00:00Z